Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Moderna Inc (NQ: MRNA )

125.67 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 4, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 133
Open 125.67
Bid (Size) 124.65 (1)
Ask (Size) 126.00 (1)
Prev. Close 125.67
Today's Range 125.67 - 125.67
52wk Range 115.03 - 376.65
Shares Outstanding 392,000,000
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Check Out What Whales Are Doing With MRNA
Someone with a lot of money to spend has taken a bearish stance on Moderna (NASDAQ:MRNA). And retail traders should know. We noticed this today when the big position showed up on publicly available... 
Via Benzinga
Moderna, Zscaler And This Biotechnology Stock Insiders Are Selling
US crude oil futures traded higher this morning on Monday. Investors, meanwhile, focused on some notable insider trades. 
Via Benzinga

Performance

YTD
-46.53%
-46.53%
1 Month
-3.39%
-3.39%
3 Month
-19.20%
-19.20%
6 Month
-22.45%
-22.45%
1 Year
-61.45%
-61.45%

More News

Read More
Google Now Shuts Down Translate App In China, Moderna-China COVID-19 Sales Talk Collapse, Disney-Dish Temporary Accord Ends Weekend Blackout: Top Stories Monday, Oct. 03
Via Benzinga
Biotech Company Pleased With Results Of Early Testing Demonstrating Vaccine Potential For Multiple Sclerosis
Via Benzinga
Moderna Creates New Executive Committee Role Ahead of New Product Launches
Via ACCESSWIRE
Moderna Says No To China's Request To Handover COVID-19 Vaccine Technology: Report
Via Benzinga
Top Five Weekend Stock Stories - Sunday, Oct. 2nd
Via Talk Markets
7 S&P 500 Stocks to Sell Before They Die
Via InvestorPlace
This Is What Whales Are Betting On Moderna
Via Benzinga
Europe's Health Agency Accepts Moderna's Filing For Its Updated Omicron-Targeted COVID-19 Vaccine
Via Benzinga
European Medicines Agency Accepts Moderna's Conditional Marketing Authorization Filing for its Omicron BA.4/BA.5 Targeting Bivalent COVID-19 Vaccine
Via ACCESSWIRE
Looking Into Moderna's Recent Short Interest
Via Benzinga
The 7 Best Stocks to Buy to Tap Into a Hidden Bull Market
Via InvestorPlace
As Moderna Grapples With Supply Shortage, FDA Gives Nod To Additional Lots of COVID-19 Booster
Via Benzinga
iPhone 14 Popular In China?, Netflix May Lose Comics, Elon Musk's Starlink Slows, Byron Allen Faces $10B Lawsuit And More Top Financial Media Stories Monday, Sept. 26
Via Benzinga
Walmart, Foot Locker And This Covid-19 Vaccine Stock Insiders Are Selling
Via Benzinga
Pfizer CEO Contracts COVID-19 Infection For Second Time
Via Benzinga
Moderna Seeks FDA Approval For Updated COVID-19 Shot For Kids, But Scrambles Supply Challenges
Via Benzinga
Switzerland To Dispose 10M Expired COVID-19 Vaccine Doses From Moderna
Via Benzinga
Pharma Giants Moderna And Novavax Trend Lower In This Pattern: What's Going On?
Via Benzinga
Here Are Novavax's U.S. Vaccination Numbers — And They're Bleak
Via Investor's Business Daily
Why Is Novavax (NVAX) Stock Falling Today?
Via InvestorPlace
Cramer On COVID-19 Vaccine Stock: 'I Know It Can Go Lower, But I Think It's A Really Well-Run Company'
Via Benzinga
Novavax Remains a Risk-On Stock in a Risk-Off Market
Via MarketBeat
Topics Earnings
Exposures Financial
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.